FFCP PHASE1:Hg19::chr11:57156748..57156766,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=novel_coding | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:57156748..57156766,- | |||
|coexpression_cluster_id=C50 | |||
|description=CAGE_peak_at_chr11:57156748..57156766,- | |||
|id=chr11:57156748..57156766,- | |||
|ontology_enrichment_celltype=CL:0002541!7.44e-25!3;CL:0000764!1.27e-16!2;CL:0000765!1.27e-16!2;CL:0000050!1.27e-16!2;CL:0000038!1.27e-16!2;CL:0000558!1.27e-16!2;CL:0000547!1.27e-16!2;CL:0000549!1.27e-16!2;CL:0000550!1.27e-16!2;CL:0000552!1.27e-16!2;CL:0000763!1.27e-07!112;CL:0000049!1.27e-07!112;CL:0002537!3.57e-07!5 | |||
|ontology_enrichment_celltype_v019=CL:0002541;1.01e-74;3!CL:0000349;2.09e-21;19!CL:0000723;6.71e-07;61 | |||
|ontology_enrichment_celltype_v019_2=CL:0002541,1.01e-74,3;CL:0000349,2.09e-21,19 | |||
|ontology_enrichment_development_v019=UBERON:0003124;4.61e-26;1 | |||
|ontology_enrichment_disease=DOID:8692!3.26e-11!31;DOID:225!2.22e-09!1;DOID:8552!2.82e-09!1;DOID:1036!4.58e-09!8;DOID:1240!9.39e-09!39 | |||
|ontology_enrichment_disease_v019=DOID:225;7.62e-26;1!DOID:8552;1.26e-25;1!DOID:74;1.21e-13;2!DOID:1287;1.80e-07;4 | |||
|ontology_enrichment_disease_v019_2=DOID:225,5.93e-26,1;DOID:8552,1.26e-25,1;DOID:74,1.07e-13,2;DOID:1287,1.69e-07,4 | |||
|ontology_enrichment_uberon=UBERON:0000476!7.44e-25!3;UBERON:0000920!7.44e-25!3;UBERON:0005631!4.71e-20!14;UBERON:0000158!4.71e-20!14;UBERON:0003124!1.10e-18!7;UBERON:0000478!1.70e-11!24;UBERON:0002146!7.85e-09!1;UBERON:0005623!7.85e-09!1 | |||
|ontology_enrichment_uberon_v019=UBERON:0003124;1.01e-74;3!UBERON:0000920;1.01e-74;3!UBERON:0005631;4.30e-40;10!UBERON:0000158;4.30e-40;10!UBERON:0000478;4.02e-26;24!UBERON:0001987;1.59e-07;4 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000920,1.01e-74,3;UBERON:0003124,6.87e-57,7;UBERON:0005631,1.96e-44,14;UBERON:0000158,1.96e-44,14;UBERON:0000478,4.02e-26,24;UBERON:0004923,1.09e-09,66;UBERON:0001987,1.59e-07,4;UBERON:0004340,1.59e-07,4 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.645484683583826,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.521482918420201,0,0,0,0.316462387440884,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.263384084775077,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.877039506583738,0.522870902049801,0,0,0,0.412164046590889,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.564862804660675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191505370132367,0.211673582723883,0,0,0,0.47003968731907,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,13.6084356300483,0.296964680832639,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,60.6102203490647,2.47313502185028,85.8185989390002,0,2.04074333313532,1.82832850090172,0,0,0,0,0.158936578980379,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.61214552326098,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229160424011684,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.082092520749339,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.66729324235352,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.01588058552972,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0852134047591577,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.426467963801962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:57156748..57156766,- | |||
}} |
Latest revision as of 22:55, 23 July 2015
Short description: | p@chr11:57156748..57156766, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr11:57156748..57156766, - |
Coexpression cluster: | C50_chorionic_placenta_amniotic_migratory_smallcell_chronic_choriocarcinoma |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chorionic membrane mesenchymal stem cell | 1.01e-74 | 3 |
extraembryonic cell | 2.09e-21 | 19 |
Ontology term | p-value | n |
---|---|---|
egg chorion | 1.01e-74 | 3 |
chorion | 6.87e-57 | 7 |
extraembryonic membrane | 1.96e-44 | 14 |
membranous layer | 1.96e-44 | 14 |
extraembryonic structure | 4.02e-26 | 24 |
organ component layer | 1.09e-09 | 66 |
placenta | 1.59e-07 | 4 |
allantois | 1.59e-07 | 4 |
Ontology term | p-value | n |
---|---|---|
syndrome | 5.93e-26 | 1 |
chronic myeloid leukemia | 1.26e-25 | 1 |
hematopoietic system disease | 1.07e-13 | 2 |
cardiovascular system disease | 1.69e-07 | 4 |